Breast Neoplasms: all 12,820 studies
Page 82 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- CESM ABMR Breast Cancer Screening TrialCompletedNCT03517813
- A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
- Fish Oil and EPO in Breast CancerStatus unknownNCT03516253Not applicable
- MIAMI Safe Surgery for Multiple Breast CancersCompletedNCT03514654Not applicable
- Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)Active, not recruitingNCT03513614Not applicable
- Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and DiagnosticsStatus unknownNCT03511859
- Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast CancerCompletedNCT03511781Not applicable
- Music as a Perioperative Therapy in Breast Cancer PatientsWithdrawnNCT03511079Not applicable
- Erector Spinae Block in Segmental Mastectomy.Status unknownNCT03509090Not applicable
- Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast CancerStatus unknownNCT03507465Phase 2/3
- Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast CancerCompletedNCT03507088Not applicable
- An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast CancerCompletedNCT03505528Phase 1
- The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. PredictorCompletedNCT03505164
- Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on TamoxifenStatus unknownNCT03504631
- Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast CancerActive, not recruitingNCT03503799
- Serum Opiorphin Level After Intraoperative Intravenous Lidocaine InfusionCompletedNCT03502395Phase 1
- What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?Status unknownNCT03501394Not applicable
- Extended Follow up of the TARGIT-A TrialStatus unknownNCT03501121
- A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver MetastasesActive, not recruitingNCT03500380Phase 2/3
- IMpact of PRehabilitation in Oncology Via Exercise - Breast CancerCompletedNCT03498157Not applicable
- Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast CancerStatus unknownNCT03497702Phase 2
- Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast CancerStatus unknownNCT03495544
- Aerobic Training in Treatment for Breast CancerCompletedNCT03494400Not applicable
- Pembrolizumab and Paclitaxel in Hypermutated Breast CancerCompletedNCT03492918Phase 2
- Breast Cancer Active Surveillance, Alternative Option, Aspirin IncludedStatus unknownNCT03491410Phase 2/3
- Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerActive, not recruitingNCT03488693Phase 3
- Transcranial Direct Current Stimulation (tDCS) to Improve Fatigue and Cognitive FunctionCompletedNCT03487601Not applicable
- Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone MetastasesStatus unknownNCT03487055Phase 1
- Disposition of Dietary Polyphenols and Methylxanthines in Mammary Tissues From Breast Cancer PatientsCompletedNCT03482401Not applicable
- A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast CancerCompletedNCT03481998Phase 1/2
- Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMCTerminatedNCT03480659
- Integrative Approaches to Cancer Survivorship: Project 3CompletedNCT03479385Not applicable
- Self-efficacy Coaching for Women With Breast CancerCompletedNCT03478384Not applicable
- Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal CancerCompletedNCT03477019Phase 1/2
- Cognitive Dysfunction and Breast Cancer Coping Strategies Impact on QOLCompletedNCT03476226Not applicable
- Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation TestingStatus unknownNCT03475979
- An Observational Prospective Cohort Study Using an Actigraphy Device.CompletedNCT03475433
- Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast CancerStatus unknownNCT03474016
- Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast CancerWithdrawnNCT03473691Early Phase 1
- A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant TherapyCompletedNCT03473639Phase 1
- Adaptation of a Knowledges Exchange Portal Between (KEP) Healers and Patients : Obstacles and Sources to KEP Use for Breast Cancer WomenCompletedNCT03472794
- Intensity Modulated Radiotherapy With Concomitant Boost in Breast CancerCompletedNCT03471741
- A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast CancerCompletedNCT03471663Phase 1
- GlobalSurg 3: Quality and Outcomes in Global Cancer SurgeryCompletedNCT03471494
- Non-interventional Study Evaluating Gynecological Impact of Diagnosis and Treatment of Breast Cancer in Patients YoungerCompletedNCT03470935
- A Communication Skills Package to Prevent Fear of Cancer RecurrenceStatus unknownNCT03468881
- Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CTStatus unknownNCT03468374Not applicable
- Reducing Distress and Depressive-symptoms in Rural WomenCompletedNCT03465813Not applicable
- Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast CancerCompletedNCT03464942Phase 2
- Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First LineCompletedNCT03462251Phase 3
- Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast CancerCompletedNCT03461588Not applicable
- Modulated Accelerated RAdiotherapy in Early Breast CancerCompletedNCT03461224
- Omission of Radiation in Patients With Her-2 Positive Breast CancerActive, not recruitingNCT03460067Not applicable
- Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast CancerCompletedNCT03457779Not applicable
- Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast CancerStatus unknownNCT03457467Phase 2
- Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast CancerCompletedNCT03456973Not applicable
- G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast CancerCompletedNCT03455270Phase 1
- Immunogenicity and Safety of DCs in Breast CancerCompletedNCT03450044Phase 1/2
- Chemotherapy-Induced Peripheral Neuropathy-Essential Oil InterventionCompletedNCT03449303Not applicable
- Evaluating a Novel Web-based Intervention for Breast Cancer SurvivorsTerminatedNCT03448250Not applicable
- Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse BackgroundsCompletedNCT03447886
- Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to FulvestrantCompletedNCT03447132Phase 3
- Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®CompletedNCT03445637
- Neoadjuvant Goserelin for Triple Negative Breast CancerStatus unknownNCT03444025Phase 2
- Preoperative Localization of Sentinel Lymph Node in Breast Cancer Patients By Novel Computed Tomography-Lymphography Guided TechniqueStatus unknownNCT03442543Phase 1
- Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast CancerActive, not recruitingNCT03442504Not applicable
- Robotic Nipple-Sparing Mastectomy Vs Conventional Open TechniqueCompletedNCT03440398Not applicable
- Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBCActive, not recruitingNCT03439735Phase 2
- BrUOG 351: PRE-OPERATIVE APBI USING NIBBWithdrawnNCT03437915Not applicable
- Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in ChinaCompletedNCT03437837
- Accelerated Partial Breast Irradiation StudyActive, not recruitingNCT03437395Not applicable
- A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer ParticipantsCompletedNCT03437083
- Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NTActive, not recruitingNCT03435952Phase 1
- An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)CompletedNCT03433560
- Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast CancerCompletedNCT03433313Phase 3
- Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerTerminatedNCT03432741Phase 1
- Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian CancerCompletedNCT03430518Phase 1
- Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological ResilienceActive, not recruitingNCT03430492
- Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast CancerCompletedNCT03430479Phase 1/2
- Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast CancerTerminatedNCT03430466Phase 2
- Nuclear Myosin VI - a Therapeutic Target in Breast CancerStatus unknownNCT03430024
- Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer PatientsStatus unknownNCT03429972Phase 2
- An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast CancerActive, not recruitingNCT03429907Not applicable
- Impact of Body Mass Index on Outcomes of Breast Cancer ManagementStatus unknownNCT03429504
- Autohypnosis and CancerologyCompletedNCT03429296Not applicable
- A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast CancerTerminatedNCT03429101Phase 1
- Preventing Lymphedema in Axillary Lymph Node DissectionTerminatedNCT03428581Not applicable
- Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 SystemCompletedNCT03427450
- Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in Patients With Solid TumorsWithdrawnNCT03426254Phase 1
- Exercise, Fitness and Tumor Profiling in Breast Cancer PatientsActive, not recruitingNCT03424915
- The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage TherapyStatus unknownNCT03423849Phase 2/3
- PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studYActive, not recruitingNCT03423199Phase 3
- Intercostobrachial Nerve Sparing to Reduce Post-Surgical PainStatus unknownNCT03421522Not applicable
- Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of SleepCompletedNCT03420105Not applicable
- Pregnant Exposure to Persistent Organic PollutantsCompletedNCT03419026
- Antioxidant Supplements, Genetics and Chemotherapy OutcomesCompletedNCT03413761
- Web-Based Communication Education for Breast Cancer Survivorship CareStatus unknownNCT03413332Not applicable
- A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and TaxanesStatus unknownNCT03412955Phase 2
- Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 SignalingStatus unknownNCT03412643Phase 2
- Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast CancerStatus unknownNCT03412383Phase 2